Thomas S Helling

Summary

Publications

  1. doi request reprint Failure events in transition of care for surgical patients
    Thomas S Helling
    Department of Surgery, University of Mississippi Medical Center, Jackson, MS Electronic address
    J Am Coll Surg 218:723-31. 2014
  2. doi request reprint Cause of death from liver metastases in colorectal cancer
    Thomas S Helling
    Department of Surgery, University of Mississippi Medical Center, Jackson, MS, USA
    Ann Surg Oncol 21:501-6. 2014
  3. ncbi request reprint Caution in interpretation of the tumor marker CA 19.9 in patients with obstructive jaundice: illustrative case reports
    Thomas S Helling
    Department of Surgery, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA
    J Miss State Med Assoc 54:96-9. 2013

Detail Information

Publications3

  1. doi request reprint Failure events in transition of care for surgical patients
    Thomas S Helling
    Department of Surgery, University of Mississippi Medical Center, Jackson, MS Electronic address
    J Am Coll Surg 218:723-31. 2014
    ..We sought to investigate failure events requiring intensive care (surgical ICU [SICU]) transfer of surgical patients on WARDs in a single-center academic setting...
  2. doi request reprint Cause of death from liver metastases in colorectal cancer
    Thomas S Helling
    Department of Surgery, University of Mississippi Medical Center, Jackson, MS, USA
    Ann Surg Oncol 21:501-6. 2014
    ..It is presumed, but not proven, that liver metastases are a major threat to life. This study examined the course of a cohort of consecutive patients who died with CRC to determine the role played by the presence of liver metastases...
  3. ncbi request reprint Caution in interpretation of the tumor marker CA 19.9 in patients with obstructive jaundice: illustrative case reports
    Thomas S Helling
    Department of Surgery, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA
    J Miss State Med Assoc 54:96-9. 2013
    ..The CA 19.9 antigen is commonly used as a tumor marker for malignancies of the pancreas and biliary tract. High levels (> 300 U/ml) of antigen have strongly suggested malignant processes...